BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33858850)

  • 1. Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis.
    Li Z; Chen S; Cui H; Li X; Chen D; Hao W; Wang J; Li Z; Zheng Z; Zhang Z; Liu H
    Ann Rheum Dis; 2021 Jul; 80(7):891-902. PubMed ID: 33858850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis.
    Chen S; Li Z; Chen D; Cui H; Wang J; Li Z; Li X; Zheng Z; Zhan Z; Liu H
    Ann Rheum Dis; 2023 Apr; 82(4):533-545. PubMed ID: 36543525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis.
    Li X; Chen S; Hu Z; Chen D; Wang J; Li Z; Li Z; Cui H; Dai G; Liu L; Wang H; Zhang K; Zheng Z; Zhan Z; Liu H
    EMBO Mol Med; 2020 Dec; 12(12):e12109. PubMed ID: 33259138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Tenascin C on the Integrity of Extracellular Matrix and Skin Aging.
    Choi YE; Song MJ; Hara M; Imanaka-Yoshida K; Lee DH; Chung JH; Lee ST
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin-C promotes endochondral ossification and fracture healing through Hedgehog and Hippo signaling.
    Zhong F; Hao W; Chao H; Li Z; Chen S; Li S; Zhang S; Zhang K; Li Z; Liu H
    Biochem Biophys Res Commun; 2024 Apr; 703():149634. PubMed ID: 38354465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-derived tenascin-C promotes Schwann cell migration through β1-integrin dependent pathway during peripheral nerve regeneration.
    Zhang Z; Yu B; Gu Y; Zhou S; Qian T; Wang Y; Ding G; Ding F; Gu X
    Glia; 2016 Mar; 64(3):374-85. PubMed ID: 26497118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis.
    Jo S; Won EJ; Kim MJ; Lee YJ; Jin SH; Park PR; Song HC; Kim J; Choi YD; Kim JY; Shim SC; Choi SH; Park YS; Kim TH; Kim TJ
    Rheumatology (Oxford); 2021 Aug; 60(8):3923-3935. PubMed ID: 33237331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tenascin-C in a rat vocal fold injury model and its regulation of fibroblasts.
    Li J; Liu Y; Wang Y; Xu W
    Laryngoscope; 2018 Sep; 128(9):E316-E322. PubMed ID: 29572861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial organization of the tenascin-C microenvironment in experimental and human cancer.
    Spenlé C; Gasser I; Saupe F; Janssen KP; Arnold C; Klein A; van der Heyden M; Mutterer J; Neuville-Méchine A; Chenard MP; Guenot D; Esposito I; Slotta-Huspenina J; Ambartsumian N; Simon-Assmann P; Orend G
    Cell Adh Migr; 2015; 9(1-2):4-13. PubMed ID: 25611571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis.
    Helliwell PS; Porter G;
    Skeletal Radiol; 2007 Nov; 36(11):1061-6. PubMed ID: 17849113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma.
    He S; Huang Q; Hu J; Li L; Xiao Y; Yu H; Han Z; Wang T; Zhou W; Wei H; Xiao J
    Br J Cancer; 2019 Nov; 121(11):922-933. PubMed ID: 31649319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation.
    Czopka T; von Holst A; ffrench-Constant C; Faissner A
    J Neurosci; 2010 Sep; 30(37):12310-22. PubMed ID: 20844127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TGF-β signaling pathway on Tenascin C protein upregulation in a pilocarpine seizure model.
    Mercado-Gómez O; Landgrave-Gómez J; Arriaga-Avila V; Nebreda-Corona A; Guevara-Guzmán R
    Epilepsy Res; 2014 Dec; 108(10):1694-704. PubMed ID: 25445237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin-C Induces Phenotypic Changes in Fibroblasts to Myofibroblasts with High Contractility through the Integrin αvβ1/Transforming Growth Factor β/SMAD Signaling Axis in Human Breast Cancer.
    Katoh D; Kozuka Y; Noro A; Ogawa T; Imanaka-Yoshida K; Yoshida T
    Am J Pathol; 2020 Oct; 190(10):2123-2135. PubMed ID: 32650003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis.
    Gupta L; Bhattacharya S; Aggarwal A
    Clin Rheumatol; 2018 May; 37(5):1401-1405. PubMed ID: 29313272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.
    Paron I; Berchtold S; Vörös J; Shamarla M; Erkan M; Höfler H; Esposito I
    PLoS One; 2011; 6(6):e21684. PubMed ID: 21747918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix protein Tenascin-C promotes kidney fibrosis via STAT3 activation in response to tubular injury.
    Xie Q; Zhang M; Mao X; Xu M; Liu S; Shang D; Xu Y; Chen R; Guan Y; Huang X; Zent R; Pozzi A; Hao CM
    Cell Death Dis; 2022 Dec; 13(12):1044. PubMed ID: 36522320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-Derived Growth Factor B Is a Key Element in the Pathological Bone Formation of Ankylosing Spondylitis.
    Jo S; Lee SH; Park J; Nam B; Kim H; Youn J; Lee S; Kim TJ; Sung IH; Choi SH; Park YS; Inman RD; Kim TH
    J Bone Miner Res; 2023 Feb; 38(2):300-312. PubMed ID: 36422470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis.
    Fu H; Tian Y; Zhou L; Zhou D; Tan RJ; Stolz DB; Liu Y
    J Am Soc Nephrol; 2017 Mar; 28(3):785-801. PubMed ID: 27612995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway.
    Czopka T; Von Holst A; Schmidt G; Ffrench-Constant C; Faissner A
    Glia; 2009 Dec; 57(16):1790-801. PubMed ID: 19459213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.